This study was undertaken to determine the effects of progesterone on the peripheral circulation. In prepubertal female pigs anesthetized with sodium pentobarbitone, changes in the superior mesenteric, left renal and left external iliac flow caused by intravenous infusion of progesterone were assessed using electromagnetic flow meters. Changes in heart rate and arterial blood pressure were prevented by atrial pacing and by connecting the arterial system to a pressurized reservoir containing Ringer solution. In 20 pigs, infusion of 1 mg/kg of progesterone increased mesenteric, renal and iliac flow. In a further 4 pigs, the vasodilatory effects of the hormone were enhanced by graded increases in the dose between 1, 2 and 3 mg/kg. The mechanisms of these responses were studied in the 20 pigs by repeating the experiment after hemodynamic variables had returned to the control values before infusion. In 5 pigs, blockade of adrenergic receptors with propranolol and phentolamine did not affect the responses elicited by progesterone. The increases in mesenteric, renal and iliac flow to progesterone were prevented, respectively, by the injection of Nω-nitro-L-arginine methyl ester into the mesenteric (5 pigs), the renal (5 pigs) or the iliac artery (5 pigs). The present study shows that intravenous infusion of progesterone dilated mesenteric, renal and iliac circulations. The mechanism of this response involved the release of nitric oxide.

Keywords:
Blood flow, Hemodynamics, Nitric oxide, Progesterone
1.
Molinari C, Battaglia A, Grossini E, Mary DASG, Stoker JB, Surico N, Vacca G: The effect of progesterone on coronary blood flow in anaesthetized pigs. Exp Physiol 2001;86:101–108.
2.
Rupnow HL, Phernetton TM, Shaw CE, Modrick ML, Bird IM, Magness RR: Endothelial vasodilator production by uterine and systemic arteries. VII. Estrogen and progesterone effects on eNOS. Am J Physiol 2001;28:H1699–H1705.
3.
Kakucs R, Varbiro S, Szekacs B, Nadasy GL, Acs N, Monos E: Direct relaxing effect of estradiol-17beta and progesterone on rat saphenous artery. Microvasc Res 1998;56:139–143.
4.
Mather KJ, Norman EG, Prior JC, Elliot TG: Preserved forearm endothelial responses with acute exposure to progesterone: A randomized cross-over trial of 17-beta estradiol, progesterone, and 17-beta estradiol with progesterone in healthy menopausal women. J Clin Endocrinol Metab 2000;85:4644–4649.
5.
Lee AF, McFarlane LC, Struthers AD: Ovarian hormones in man: Their effects on resting vascular tone, angiotensin converting enzyme activity and angiotensin II-induced vasoconstriction. Br J Clin Pharmacol 2000;50:73–76.
6.
Mercuro G, Pitzalis L, Podda A, Zoncu S, Pilia I, Melis GB, Cherchi A: Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women. Am J Cardiol 1999;84:214–218.
7.
Vacca G, Battaglia A, Grossini E, Mary DASG, Molinari C, Surico B: The effect of 17β-oestradiol on regional blood flow in anaesthetized pigs. J Physiol (London) 1999;514:875–884.
8.
Samaan SA, Crawford MH: Estrogen and cardiovascular function after menopause. J Am Coll Cardiol 1995;26:1403–1410.
9.
Linden RJ, Mary DASG: The preparation and maintenance of anaesthetized animals for the study of cardiovascular function; in Linden RJ (ed): Techniques in Cardiovascular Physiology (Techniques in the Life Sciences series). Shannon, Elsevier, 1983, pp 1–22.
10.
Molinari C, Grossini E, Mary DASG, Vacca G: Effect of distension of the gallbladder on plasma renin activity in anesthetized pigs. Circulation 2000;101:2539–2545.
11.
Warren MP, Shantha S: Uses of progesterone in clinical practice. Int J Fertil Women Med 1999;44:96–103.
12.
Barber DA, Miller VM: Gender differences in endothelium-dependent relaxation do not involve NO in porcine coronary arteries. Am J Physiol 1997;273:H2325–H2332.
13.
Mason JM, Ledsome JR: Effects of obstruction of the mitral orifice or distension of the pulmonary vein-atrial junctions on renal hind-limb vascular resistance in the dog. Circ Res 1974;35:24–32.
14.
Mancia G, Donald DE, Shepherd JT: Inhibition of adrenergic outflow to peripheral blood vessels by vagal afferents from the cardiopulmonary region in the dog. Circ Res 1973;33:713–721.
15.
Masilami S, Heesch CM: Effects of pregnancy and progesterone metabolites on arterial baroreflex in conscious rats. Am J Physiol 1997;272:R924–R934.
16.
Laipraset JD, Rogers RC, Heesch CM: Neurosteroid modulation of arterial baroreflex-sensitive neurons in rat rostral ventrolateral medulla. Am J Physiol 1998;274:R903–R911.
17.
Vacca G, Battaglia A, Grossini E, Mary DASG, Molinari C: Reflex coronary vasoconstriction caused by gallbladder distension in anesthetized pigs. Circulation 1996;94:2201–2209.
18.
Gregory NG, Wotton SB: Autonomic and non-autonomic control of cardiovascular function in stress-sensitive pigs. J Vet Pharmacol Ther 1981;4:183–191.
19.
Henderson AH: Endothelium in control. Br Heart J 1991;65:116–125.
20.
Jones AW, Rubin LJ, Magliola L: Endothelin-1 sensitivity of porcine coronary arteries is reduced by exercise training and is gender dependent. J Appl Physiol 1999;87:1172–1177.
21.
Laughlin MH, Schrage WG, McAllister RM, Garverick HA, Jones AW: Interaction of gender and exercise training: Vasomotor reactivity of porcine skeletal muscle arteries. J Appl Physiol 2001;90:216–227.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.